Infectious episodes and hospitalization rates in the everolimus (EVR) group (n = 35 until month 24, n = 33 at month 36 and 48) and the control group (n = 70).
dataset
posted on 2015-09-25, 03:14 authored by Lena Caroline Brunkhorst, Alexander Fichtner, Britta Höcker, Greta Burmeister, Thurid Ahlenstiel-Grunow, Kai Krupka, Martin Bald, Antonia Zapf, Burkhard Tönshoff, Lars PapeData are given as median (range) or as percentage. P values were calculated by the $Wilcoxon test or by the §Fischer’s exact test. ARE, acute rejection episodes; EVR, everolimus; GI, Gastrointestinal
Infectious episodes and hospitalization rates in the everolimus (EVR) group (n = 35 until month 24, n = 33 at month 36 and 48) and the control group (n = 70).
